Ruvim Izĭckson on a joint flu and COVID-19 vaccine

The Lancet Respiratory Medicine in conversation with - A podcast by The Lancet Group

Categories:

Education

Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older. Read the full article: Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 year Continue this conversation on social! Follow us today at... https://thelancet.bsky.soci...